Description: Dr Horvath's research lies at the intersection of aging research, epidemiology, chronic diseases, epigenetics, genetics, and systems biology. He works on all aspects of biomarker development with a particular focus on genomic biomarkers of aging. He developed a highly accurate multi-tissue biomarker of aging known as the epigenetic clock. Dr Horvath developed systems biologic approaches such as weighted gene co-expression network analysis which lend themselves for integrating gene genomic data sets. These methods have been used for a broad spectrum of age-related diseases including neurodegenerative diseases, cancer, cardiovascular disease. Dr. Horvath received a Ph.D. in Mathematics from the University of North Carolina, Chapel Hill in 1995 and a Doctorate of Science in Biostatistics from the Harvard School of Public Health in 2000.

Description: Papers: Quantification and Management of Longevity Risk in China – Johnny Li, FSA, ACIA, Ph.D. - Univeristy of Melbourne, Kenneth Q. Zhou, ASA, ACIA, Ph.D. - Arizona State University, Wai-Sun Chan, FSA, CERA, Ph.D. - The Chinese University of Hong Kong A Value-Based Longevity Index for Hedging Retirement Income Portfolios – Kevin Krahe, Jonathan Ziveyi, Ph.D., Michael Sherris, FSA, FIAA, FIA, Andres M. Villegas, Ph.D. - UNSW Australia

Description: The article examines the impact of the COVID-19 pandemic on U.S. mortality trends, noting that despite a decrease in COVID-19 deaths due to better treatments and vaccinations, excess mortality persists, especially among younger adults due to accidental causes. It discusses the challenges of predicting future mortality trends, considering factors like medical advancements and societal changes. The article also highlights the potential of new medical technologies and AI to significantly improve health outcomes in the future. Overall, it underscores the complex interplay of various factors influencing mortality in the post-pandemic era.

Description: As results emerged showing the influence of COVID-19 on recent mortality, the Society of Actuaries Research Institute’s Mortality and Longevity Strategic Research Program Steering Committee (MLPSC) began to ponder what it means for the future. Was the coronavirus pandemic just a temporary shock to U.S. mortality with mortality quickly returning to prepandemic levels upon its conclusion or a lingering factor in future U.S. mortality from the potential occurrence of new coronavirus variants, post-COVID-19 conditions (“long COVID”), deferral of needed health care treatment, a fatigued health care system and other elements? Only time will provide the answers to these questions.

Description: This session will bring together public health care leaders in COVID-10 vaccine delivery from both the U.S. and the UK to discuss and compare operational implications of the COVID-19 vaccine rollout in their countries, and how those programs ultimately affected hospitalization utilization and mortality rates for members of their communities.

Description: Discover unique perspectives on insurance challenges faced by LGBTQ+ individuals and their families in this essay collection. Gain a broader understanding of these issues beyond the LGBTQ+ community. The SOA Research Institute aims to foster innovation within the actuarial and insurance industries by promoting comprehension of these insights.

Description: This report evaluates the long-term mortality consequences of the COVID-19 pandemic from a cohort-based perspective using historical mortality data.

Description: This report documents updates to the Canadian mortality data in both the Human Mortality Database and the Canadian Human Mortality Database, including new data for 2022–2023.

Description: This report covers the latest emerging trends in U.S. population mortality. The SOA relied upon data furnished by the Centers for Disease Control and Prevention (CDC). Observations are based on the CDC’s recent release of 2020 mortality experience, along with prior mortality experience data from 1999 through 2019.

Description: An analysis of U.S. mortality trends by socioeconomic category from 1982 to 2023, emphasizing the continuing effects of the COVID-19 pandemic on mortality disparities.